Cite
HARVARD Citation
Teply, B. et al. (2019). Risk of development of visceral metastases subsequent to abiraterone vs placebo: An analysis of mode of radiographic progression in COU‐AA‐302. Prostate. 79 (8), pp. 929-933. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Teply, B. et al. (2019). Risk of development of visceral metastases subsequent to abiraterone vs placebo: An analysis of mode of radiographic progression in COU‐AA‐302. Prostate. 79 (8), pp. 929-933. [Online].